Two-year outcome of an observe-and-plan regimen for neovascular age-related macular degeneration treated with Aflibercept
出版年份 2017 全文链接
标题
Two-year outcome of an observe-and-plan regimen for neovascular age-related macular degeneration treated with Aflibercept
作者
关键词
Age-related macular degeneration, Aflibercept, Anti-VEGF, Observe-and-plan regimen, Treat and extend regimen, Clinical burden, Chronic care management
出版物
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
Volume 255, Issue 11, Pages 2127-2134
出版商
Springer Nature
发表日期
2017-08-11
DOI
10.1007/s00417-017-3762-2
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Response of Pigment Epithelial Detachment to Anti–Vascular Endothelial Growth Factor Treatment in Age-Related Macular Degeneration
- (2016) Han Joo Cho et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Key drivers of visual acuity gains in neovascular age-related macular degeneration in real life: findings from the AURA study
- (2016) Frank G Holz et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Erratum: Two-year outcome of an observe-and-plan regimen for neovascular age-related macular degeneration: how to alleviate the clinical burden with maintained functional results
- (2015) C Gianniou et al. EYE
- Prospective Trial of Treat-and-Extend versus Monthly Dosing for Neovascular Age-Related Macular Degeneration
- (2015) Charles C. Wykoff et al. OPHTHALMOLOGY
- Optimizing the Anti-VEGF Treatment Strategy for Neovascular Age-Related Macular Degeneration: From Clinical Trials to Real-Life Requirements
- (2015) Irmela Mantel Translational Vision Science & Technology
- Reducing the clinical burden of ranibizumab treatment for neovascular age-related macular degeneration using an individually planned regimen
- (2014) Irmela Mantel et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Two-year outcome of an observe-and-plan regimen for neovascular age-related macular degeneration: how to alleviate the clinical burden with maintained functional results
- (2014) C Gianniou et al. EYE
- Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial
- (2013) Usha Chakravarthy et al. LANCET
- Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials
- (2013) Juan E. Grunwald et al. OPHTHALMOLOGY
- Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration
- (2013) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGY
- Prospective study evaluating the predictability of need for retreatment with intravitreal ranibizumab for age-related macular degeneration
- (2012) Irmela Mantel et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- Myositis Ossificans
- (2011) Deborah A. Martin et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Treat and Extend Regimen Using Ranibizumab for Neovascular Age-Related Macular DegenerationClinical and Economic Impact
- (2010) Omesh P. Gupta et al. OPHTHALMOLOGY
- Efficacy and Safety of Monthly versus Quarterly Ranibizumab Treatment in Neovascular Age-related Macular Degeneration: The EXCITE Study
- (2010) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGY
- A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study
- (2009) Geeta A. Lalwani et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1
- (2008) Carl D. Regillo et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation